High Quality Independent From a Donor: Human Amniotic Fluid Derived Stem Cells-A Practical Analysis Based on 165 Clinical Cases

J Cell Biochem. 2017 Jan;118(1):116-126. doi: 10.1002/jcb.25618. Epub 2016 Jun 28.

Abstract

The aim of the study was to extend the potential use of human stem cells isolated from amniotic fluid in medical applications by confirming their high homogeneity and quality. Amniotic fluid samples were collected during amniocentesis from 165 women during pregnancy. The proliferation rate, clonogenicity, karyotype, aging process, pluripotent cell markers, expression of surface markers, and the potential to differentiate into adipose, bone and cartilage cells of hAFSCs were analyzed. Obtained results revealed that mesenchymal stem cells could be derived successfully from amniotic fluid, which exhibit properties comparable with MSCs of other origins. It is the first study, in which such a large group of patients was involved. Comprehensive statistical and biological analysis were conducted some of which clearly being innovative in relation to human amniotic fluid-derived stem cells. J. Cell. Biochem. 118: 116-126, 2017. © 2016 Wiley Periodicals, Inc.

Keywords: AMNIOTIC FLUID; BIOLOGICAL EVALUATION; STEM CELLS.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Amniotic Fluid* / cytology
  • Amniotic Fluid* / metabolism
  • Antigens, Differentiation / biosynthesis
  • Cell Proliferation / physiology
  • Cell Separation / methods*
  • Cell Separation / standards
  • Cellular Senescence / physiology
  • Female
  • Humans
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / metabolism
  • Middle Aged
  • Pluripotent Stem Cells* / cytology
  • Pluripotent Stem Cells* / metabolism
  • Pregnancy

Substances

  • Antigens, Differentiation